Clinical trial Recruiting at 1 site Observational Ages 18 to 40 Women only

Identifying biomarkers for neurodevelopmental disorders linked to inflammation during pregnancy

Official title: Predictive BioMArkers of AlTERed NeurologicAL Trajectories Consequent to PrenataL

Run by Istituto Clinico Humanitas · NCT06852703 · Data updated 2026-11-12

This study is trying to find signs that could help predict neurodevelopmental disorders in kids whose moms had inflammation during pregnancy.

Quick facts

Study typeObservational
Ages18 Years to 40 Years
SexWomen only
Enrollment300 (estimated)
SponsorIstituto Clinico Humanitas
Academic / other
Locations1 site (Pisa, PI)
StatusRecruiting
StartedSeptember 1, 2021
Main results expectedApril 30, 2024
Study endsAugust 31, 2025
Registry record updatedFebruary 28, 2025
Trial IDNCT06852703 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are pregnant women aged 18 to 40 with a normal BMI and no significant medical or obstetric history.

Probably not a fit

Patients with pre-gestational diabetes, multiple pregnancies, or significant obstetric complications will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to identify predictive biomarkers for neurodevelopmental disorders in children whose mothers experienced inflammation during pregnancy. It will involve 300 pregnant women and their children, with biological samples collected at various stages of pregnancy to assess immune responses. The study will also utilize a controlled mouse model to explore the molecular mechanisms connecting maternal inflammation to altered brain development. The integration of these approaches seeks to provide early indicators and potential intervention strategies for affected children.

Why it matters

Potential benefit: If successful, this study could lead to early identification and intervention strategies for neurodevelopmental disorders in children.

How similar studies have gone: While the association between maternal inflammation and neurodevelopmental disorders is established, this specific approach to identifying biomarkers is novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Age between 18 and 40 years. BMI between 18 kg/m2 and 25 kg/m2. Negative remote medical history for chronic conditions (rheumatological, immunological, endocrinological).

Negative obstetric history for significant pathologies (pre-eclampsia, gestational diabetes, preterm birth).

Reassuring combined test

Exclusion Criteria:

* Pre-gestational diabetes
* Multiple pregnancy
* Threatened preterm labor and/or premature rupture of membranes
* Pre-eclampsia
* Intrauterine growth restriction (IUGR)
* Fetal macrosomia (biometrics \>90th percentile)
* Chromosomal syndromes, genetic conditions, or multiple fetal malformations or major fetal malformations
* Withdrawal of informed consent
* Smoking patients are not excluded from the study, nor are patients who develop gestational diabetes during pregnancy.

Where it's running

  • Aoup
    Pisa, Pi, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.